Country

Clinical trials in Colombia

Active obesity and GLP-1 studies with at least one location in Colombia.

3active studies

1recruiting now

18countries represented

121largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

Overweight, ObesityCondition

Cagrilintide, SemaglutideTreatment

Australia, Austria121 locations

Novo Nordisk A/SSponsor

Updated 2026-08-31 · NCT07253285See eligibility →

Opening soonNot applicable

Type 2 Diabetes, Obesity & OverweightCondition

Glucerna, Caloric restrictionTreatment

Colombia1 locations

Hospital Universitario San IgnacioSponsor

Updated 2026-06-24 · NCT07666581See eligibility →

Opening soonPhase 3

Diabetes Mellitus, Type 2Condition

CagriSema (Cagrilintide B and Semaglutide I), Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)Treatment

Argentina, Brazil56 locations

Novo Nordisk A/SSponsor

Updated 2026-05-28 · NCT07282613See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.